| Labatec Pharma SA - Yselty 100 mg, comprimés pelliculés | | 69692 | | 01 | | Yselty 100 mg | | comprimés pelliculés | | H01CC04 | | Linzagolix | | 19.01.2026 | | |
| | Composition | | Comprimé pelliculé: linzagolixum 100 mg ut linzagolixum cholinum, lactosum monohydricum 125.7 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium max. 1.8 mg, magnesii stearas, pellicule: copolymerum macrogolo et alcoholi poly(vinylico) constatum, talcum, E 171, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose | additional_information |
|---|
| Linzagolixum | 100 mg | Comprimé pelliculé |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | Copolymerum Macrogolo et Alcoholi Poly(Vinylico) Constatum | | pellicule | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hydroxypropylcellulosum Substitutum Humile | | | | Lactose Monohydrate | 125.7 mg | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Talcum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 28 | | | B | | Yes | | 002 | 84 | | | B | | Yes |
|
|
